Search Results

Current dosimetric practices do not provide comprehensive classification of high-energy charged particle radiation, so that the ability to adequately project health risk to astronaut crews is limited. To address this shortcoming in dosimetry for Space Station missions, a new generation of active radiation monitors is being developed to supplement traditional dosimetry. One active monitor is a Tissue Equivalent Proportional Counter (TEPC) to measure the linear energy transfer (LET) spectrum of space radiation. Two versions of a second type of active monitor, the Charged Particle Directional Spectrometer (CPDS), will be deployed, one internal and one external to the Station. The CPDS consists of a stack of lithium-drifted silicon detectors used to classify the radiation by particle charge and energy. The comprehensive data set obtained by using the TEPC and the CPDS permits significant improvement in assessing crew radiation exposures.

One of the risks associated with long-term space flights is cancer incidence resulting from chronic exposure to space radiation. Assessment of incurred risk from radiation exposure requires quantifying the dose throughout the body. The space radiation exposure received by Space Shuttle astronauts is measured by thermoluminescent dosimeters (TLDs) worn during every mission. These dosimeters measure the absorbed dose to the skin, but the dose to internal organs is required for estimating the cancer risk induced by space radiation. A method to extrapolate these skin dose measurements to realistic organ specific dose estimates, using the Computerized Anatomical Man (CAM) and Computerized Anatomical Female (CAF) models, is discussed in detail. A transport code, which propagates high energy nucleon and charged particles, is combined with the CAM/CAF-generated shielding areal distributions to evaluate the absorbed dose at selected organ sites.